The median time from MBC to BM diagnosis differed by tumor biology with the longest time to BM diagnosis seen in patients with HR+/HER2- MBC and shortest time to BM diagnosis in patients with TNBC, confirming trends in prior studies [26, 38]. Here, ERBB2 is linked to neoplasm.